Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Renalytix Plc (RENX)

Price 8.25p on 04-10-2024 at 16:30:01
Change 0.00p 0%
Buy 8.50p
Sell 8.00p
Buy / Sell RENX Shares
Last Trade: Sell 20,000.00 at 8.025p
Day's Volume: 207,897
Last Close: 8.25p
Open: 8.25p
ISIN: GB00BYWL4Y04
Day's Range 8.25p - 8.25p
52wk Range: 7.50p - 63.50p
Market Capitalisation: £14m
VWAP: 8.344414p
Shares in Issue: 166m

Recent Trades History Renalytix Plc (RENX)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 20,000 8.025p Ordinary
15:32:14 - 04-Oct-24
Sell* 2,137 8.025p Ordinary
13:34:01 - 04-Oct-24
Sell* 1,574 8.08p Ordinary
12:09:11 - 04-Oct-24
Unknown* 3,521 8.25p Ordinary
11:29:38 - 04-Oct-24
Unknown* 1,703 8.25p Ordinary
11:27:19 - 04-Oct-24
Unknown* 166,000 8.40p Ordinary
08:47:54 - 04-Oct-24
Unknown* 12,498 8.25p Ordinary
08:49:33 - 04-Oct-24
Sell* 464 8.20p Ordinary
08:04:27 - 04-Oct-24

Share Price History for Renalytix Plc

Time period:
to
Date Open High Low Close Volume

Share News for Renalytix Plc

Renalytix rises amid well supported fund raise; narrowed annual loss

1st Oct 2024 15:53

(Alliance News) - Renalytix PLC on Tuesday announced a successful fund raise alongside a narrowed annual loss. Read More

LONDON MARKET CLOSE: Oil price hurts FTSE and investors dial out of BT

20th Aug 2024 16:59

(Alliance News) - Falling oil prices which knocked share prices of index heavyweights, BP and Shell, plus a sharp drop in BT, weighed on London's blue-chip index on Tuesday. Read More

IN BRIEF: Renalytix ends sale process without offer; considers funding

20th Aug 2024 13:15

Renalytix PLC - London-based in vitro diagnostics for kidney disease - Shares fall as Renalytix ends the formal sale process it launched back in March without an offer. Based on its discussions to date, the board doesn't think there is a "realistic prospect" of a takeover offer in the "near term". Renalytix says it is in talks with "key stakeholders" in the company about "a suitable capital structure and funding". Cash runway extends into the fourth quarter of this year based on its cash position of USD4.7 million on June 30. Read More

EARNINGS AND TRADING: Thruvision loss widens but Polarean loss narrows

28th Jun 2024 19:46

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Shares in Renalytix plunge on possible ADS suspension on Nasdaq

25th Jun 2024 11:43

(Alliance News) - Renalytix PLC on Tuesday said a possible suspension of trading in the company's American depositary shares on Nasdaq could impair its ability to raise capital. Read More

FTSE 100 Latest
Value8,280.63
Change-1.89

Login to your account

Forgot Password?

Not Registered